Okay, so there's this company called Iovance Biotherapeutics that makes medicines to help people get better. Some really rich and smart people think this company is going to do very well in the future, so they are spending a lot of money to buy special contracts called options that give them the right to buy or sell more shares of the company later on. This usually means they know something good is about to happen with the company. Read from source...

1. The headline implies that there is a surge in options activity for IOVA, but the body of the article does not provide any evidence or data to support this claim. It seems like an exaggeration or a clickbait title to attract readers.
2. The article claims that investors with a lot of money have taken a bullish stance on IOVA, but it does not specify who these investors are, how much money they have, or what their sources of information are. This is a vague and unsubstantiated statement that lacks credibility.
3. The article mentions that the positions showed up on publicly available options history, but it does not explain why this is relevant or important for retail traders to know. It also does not provide any context or analysis of these trades, such as their timing, size, direction, or impact on the stock price.
4. The article states that when something this big happens with IOVA, it often means somebody knows something is about to happen. This is a speculative and fallacious argument that assumes causation without evidence. It also implies that retail traders should follow the actions of these big-money investors, but it does not offer any reasons or criteria for why they should do so.
5. The article reveals that Benzinga's options scanner spotted 9 options trades for IOVA, and that this is not normal. However, it does not define what constitutes a normal or abnormal number of options trades, nor does it compare this figure to other similar companies or sectors. It also does not indicate whether these trades are bullish or bearish, or how they affect the overall sentiment of IOVA's options market.